GBC - Geneva Biotech Center Swiss company who selects promising compounds, ensures their development in association with financial partners and delivers innovative thérapies.
http://www.genevabiotechcenter.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
2 seconds
16x16
32x32
64x64
128x128
Geneva Biotech Center
ch. de●●●●●●rets 6
CH●●CY , 1284
CH
View this contact
Geneva Biotech Center
Robert SLOOVES
ch. de●●●●●●rets 6
CH●●CY , 1284
CH
View this contact
Geneva Biotech Center
Robert SLOOVES
ch. de●●●●●●rets 6
CH●●CY , 1284
CH
View this contact
Geneva Biotech Center
Robert SLOOVES
ch. de●●●●●●rets 6
CH●●CY , 1284
CH
View this contact
BUY YOUR DOMAIN
13
YEARS
2
MONTHS
23
DAYS
KEY-SYSTEMS GMBH
WHOIS : whois.rrpproxy.net
REFERRED : http://www.key-systems.net
PAGES IN
THIS WEBSITE
5
SSL
EXTERNAL LINKS
41
SITE IP
128.65.195.128
LOAD TIME
1.956 sec
SCORE
6.2
Geneva Biotech Center | Providing quality investment opportunities in pharmaceutical R&D | genevabiotechcenter.com Reviews
https://genevabiotechcenter.com
GBC - Geneva Biotech Center Swiss company who selects promising compounds, ensures their development in association with financial partners and delivers innovative thérapies.
genevabiotechcenter.com
Geneva Biotech Center | our Mission
http://genevabiotechcenter.com/en/about-gbc/our-mission
GBC SA licenses exclusive worldwide rights to preclinical molecule from the University of Zurich. GBC-Atrial SA licenses Worldwide Rights to a Compound Developped by Actelion Pharmaceutical Ltd. The mission of the Geneva Biotech Center is to select promising projects, ensure their development in association with financial partners according to pharmaceutical quality standards, in order to provide solid foundations for innovative therapies, with a focus on rare and orphan diseases, neurology and immunology.
Geneva Biotech Center | Sitemap
http://genevabiotechcenter.com/en/sitemap
Content Area with Left Sidebar. Content Area with Right Sidebar. Dr Christine Serratrice, MD. Dr Jeffrey Shaw, Ph.D. Robert H. Slooves, MSc. Two Sidebars on Different Sides. Two Sidebars on the Left Side. Two Sidebars on the Right Side. GBC SA licenses exclusive worldwide rights to preclinical molecule from the University of Zurich. GBC-Atrial SA licenses Worldwide Rights to a Compound Developped by Actelion Pharmaceutical Ltd. Leave a Reply Cancel reply. Your email address will not be published.
Geneva Biotech Center | our Strengths
http://genevabiotechcenter.com/en/our-services/our-strength
GBC SA licenses exclusive worldwide rights to preclinical molecule from the University of Zurich. GBC-Atrial SA licenses Worldwide Rights to a Compound Developped by Actelion Pharmaceutical Ltd. Our development process is based on the industry standards of reference which allow us to provide the highest quality of work. Our strength lies in our partnership with academic institutions whose principle elements are as follows:. This translational and personalized approach, which includes all the key phases o...
Geneva Biotech Center | Providing quality investment opportunities in pharmaceutical R&D
http://genevabiotechcenter.com/fr
ParseInt(jQuery('#bwg current image key').val() - iterator() % data.length : data.length - 1, data); return false;". The Geneva Biotech Center. Providing quality investment opportunities in pharmaceutical Research and Development. Le GBC SA obtient les droits mondiaux sur une molécule en phase préclinique de l’Université de Zurich. GBC-Atrial S.A. obtient les droits mondiaux sur un composé développé par Actelion Pharmaceuticals Ltd. The GBC appoints new Chief Medical Officer Geneva, Switzerland, Septembe...
Geneva Biotech Center | our Team
http://genevabiotechcenter.com/en/our-team
GBC SA licenses exclusive worldwide rights to preclinical molecule from the University of Zurich. GBC-Atrial SA licenses Worldwide Rights to a Compound Developped by Actelion Pharmaceutical Ltd. Experienced scientists who have a record of achievement including numerous publications, patents and commercial successes in rare diseases and multiple sclerosis, our team is supported by project managers with specialty training on all aspects from discovery of the drug through its clinical development.
TOTAL PAGES IN THIS WEBSITE
5
Geneva Biotech Center | Sitemap
http://www.gbc-sa.org/en/sitemap
Content Area with Left Sidebar. Content Area with Right Sidebar. Dr Christine Serratrice, MD. Dr Jeffrey Shaw, Ph.D. Robert H. Slooves, MSc. Two Sidebars on Different Sides. Two Sidebars on the Left Side. Two Sidebars on the Right Side. GBC SA licenses exclusive worldwide rights to preclinical molecule from the University of Zurich. GBC-Atrial SA licenses Worldwide Rights to a Compound Developped by Actelion Pharmaceutical Ltd. Leave a Reply Cancel reply. Your email address will not be published.
Geneva Biotech Center | Sitemap
http://www.gbc-sa.com/en/sitemap
Content Area with Left Sidebar. Content Area with Right Sidebar. Dr Christine Serratrice, MD. Dr Jeffrey Shaw, Ph.D. Robert H. Slooves, MSc. Two Sidebars on Different Sides. Two Sidebars on the Left Side. Two Sidebars on the Right Side. GBC SA licenses exclusive worldwide rights to preclinical molecule from the University of Zurich. GBC-Atrial SA licenses Worldwide Rights to a Compound Developped by Actelion Pharmaceutical Ltd. Leave a Reply Cancel reply. Your email address will not be published.
Geneva Biotech Center | our Team
http://www.gbc-sa.com/en/our-team
GBC SA licenses exclusive worldwide rights to preclinical molecule from the University of Zurich. GBC-Atrial SA licenses Worldwide Rights to a Compound Developped by Actelion Pharmaceutical Ltd. Experienced scientists who have a record of achievement including numerous publications, patents and commercial successes in rare diseases and multiple sclerosis, our team is supported by project managers with specialty training on all aspects from discovery of the drug through its clinical development.
Geneva Biotech Center | Providing quality investment opportunities in pharmaceutical R&D
http://www.gbc-sa.com/fr
ParseInt(jQuery('#bwg current image key').val() - iterator() % data.length : data.length - 1, data); return false;". The Geneva Biotech Center. Providing quality investment opportunities in pharmaceutical Research and Development. GBC SA licenses exclusive worldwide rights to preclinical molecule from the University of Zurich. GBC-Atrial SA licenses Worldwide Rights to a Compound Developped by Actelion Pharmaceutical Ltd. 15 Avenue de Sécheron, 1202 Geneva, Switzerland.
Geneva Biotech Center | our Team
http://www.gbc-sa.info/en/our-team
GBC SA licenses exclusive worldwide rights to preclinical molecule from the University of Zurich. GBC-Atrial SA licenses Worldwide Rights to a Compound Developped by Actelion Pharmaceutical Ltd. Experienced scientists who have a record of achievement including numerous publications, patents and commercial successes in rare diseases and multiple sclerosis, our team is supported by project managers with specialty training on all aspects from discovery of the drug through its clinical development.
Geneva Biotech Center | Providing quality investment opportunities in pharmaceutical R&D
http://www.gbc-sa.info/fr
ParseInt(jQuery('#bwg current image key').val() - iterator() % data.length : data.length - 1, data); return false;". The Geneva Biotech Center. Providing quality investment opportunities in pharmaceutical Research and Development. GBC SA licenses exclusive worldwide rights to preclinical molecule from the University of Zurich. GBC-Atrial SA licenses Worldwide Rights to a Compound Developped by Actelion Pharmaceutical Ltd. 15 Avenue de Sécheron, 1202 Geneva, Switzerland.
Geneva Biotech Center | Providing quality investment opportunities in pharmaceutical R&D
http://www.gbc-sa.net/fr
ParseInt(jQuery('#bwg current image key').val() - iterator() % data.length : data.length - 1, data); return false;". The Geneva Biotech Center. Providing quality investment opportunities in pharmaceutical Research and Development. GBC SA licenses exclusive worldwide rights to preclinical molecule from the University of Zurich. GBC-Atrial SA licenses Worldwide Rights to a Compound Developped by Actelion Pharmaceutical Ltd. 15 Avenue de Sécheron, 1202 Geneva, Switzerland.
Geneva Biotech Center | Providing quality investment opportunities in pharmaceutical R&D
http://www.gbc-sa.org/fr
ParseInt(jQuery('#bwg current image key').val() - iterator() % data.length : data.length - 1, data); return false;". The Geneva Biotech Center. Providing quality investment opportunities in pharmaceutical Research and Development. GBC SA licenses exclusive worldwide rights to preclinical molecule from the University of Zurich. GBC-Atrial SA licenses Worldwide Rights to a Compound Developped by Actelion Pharmaceutical Ltd. 15 Avenue de Sécheron, 1202 Geneva, Switzerland.
Geneva Biotech Center | our Team
http://www.gbc-sa.org/en/our-team
GBC SA licenses exclusive worldwide rights to preclinical molecule from the University of Zurich. GBC-Atrial SA licenses Worldwide Rights to a Compound Developped by Actelion Pharmaceutical Ltd. Experienced scientists who have a record of achievement including numerous publications, patents and commercial successes in rare diseases and multiple sclerosis, our team is supported by project managers with specialty training on all aspects from discovery of the drug through its clinical development.
Geneva Biotech Center | our Team
http://www.gbc-sa.net/en/our-team
GBC SA licenses exclusive worldwide rights to preclinical molecule from the University of Zurich. GBC-Atrial SA licenses Worldwide Rights to a Compound Developped by Actelion Pharmaceutical Ltd. Experienced scientists who have a record of achievement including numerous publications, patents and commercial successes in rare diseases and multiple sclerosis, our team is supported by project managers with specialty training on all aspects from discovery of the drug through its clinical development.
TOTAL LINKS TO THIS WEBSITE
41
Geneva Bible Church
Rev TR. Penry is seeking to establish a Reformation minded congregation that is dedicated to the Lordship of Jesus Christ; secondary to that, dedicated to the basic tenants of the Reformation - Sola Scriptura ("by Scripture alone"), Sola Fide ("by faith alone"), Sola Gratia ("by grace alone"), Solo Christo ("through Christ alone"), Soli Deo Gloria ("glory to God alone"). www.thomaspenry.com. THE CONFESSION OF FAITH. 2015-2017 Geneva Bible Church. Powered by Online Church Solutions.
Geneva Bierce-Wilson | artwork
September 17, 2012. I’ve seen your art make people cry. I’ve known it to transform their perception immediately. That is what I mean by breaking people’s hearts. September 07, 2012. July 09, 2012. Here is a detail from my cob building at Warren Wilson College.
GBC : Geneva Bicycle Center : Home
GenevaBills - Payment solutions
Rue de l'Athénée, 22. Email: office (at) genevabills.com. Numéro fédéral: CH-660.1.416.014-4. Need informations about a payment? To get more information about a payment showing Genevabills on your bank or credit card statement, please submit the following form:. Anything marked after the text "GenevaBills-" on your bank or credit card statement. Genevabills will not accept any payment by wire or credit card for the following prohibited and restricted items. Animals and wildlife products.
Wholesale Supplier of Antiulcer Drug & Pharmaceutical Injection by Geneva Biocare, Chandigarh
Your Enquiry has been sent successfully. Pharmaceutical Syrup and Suspension. Protein and Calcium Supplement. Pharma PCD In Madhya Pradesh. Pharma PCD In Maharashtra. Pharma PCD in Andhra Pradesh. Pharma PCD in Tamilnadu. Pharma PCD in Kerela. Pharma PCD in Rajasthan. Pharma PCD in Assam. Pharma PCD in Orissa. Pharma PCD in U P. Pharma PCD in Bihar. Pharma PCD in Karnataka. Pharma PCD in Jharkhand. PCD Pharma Company In Tamil Nadu. Established in the year 2011. We, “Geneva Biocare”. I want to buy.
Geneva Biotech Center | Providing quality investment opportunities in pharmaceutical R&D
ParseInt(jQuery('#wdwts current image key').val() - iterator() % wdwts data.length : wdwts data.length - 1, wdwts data); return false;". The Geneva Biotech Center. Providing quality investment opportunities in pharmaceutical Research and Development. GBC-Atrial SA successfully completes clinical phase 1 Trial and prepares next projects. GBC moves to Innovation Center. GBC SA licenses exclusive worldwide rights to preclinical molecule from the University of Zurich. The Geneva Biotech Center SA.
Welcome
LIVE FAST, EAT WELL. Monday - Saturday: 10am-4pm. Friday BBQ: Spring 2018. New Years Eve (Closed). New Years Day (Closed).
Geneva Expat | Your go-to Geneva blog
Your go-to Geneva blog. Guide for an Expat, Geneva Switzerland. Living in Geneva – A City Home to Famous Educational Institutions. Guide for the Expat – Geneva Switzerland, The Best Place to Be. Living in Geneva Switzerland – A Guide to Geneva Transport. Expats in Geneva-Living Confidently in an International City. International Travel to Switzerland with Pets. Guinea Pig and Budgie Owners under the Swiss Fed’s Thumb Can I Take Pets to Geneva? Emergency Vet Geneva 022 755 55 33. Geneva is an internationa...
Geneva Expat | A Geneva blog to remember
A Geneva blog to remember. Guide for the Expat – Geneva Switzerland, The Best Place to Be. Geneva Expat Guide – Geography and Climate in Geneva. Expats in Geneva-Living Confidently in an International City. Guide for an Expat, Geneva Switzerland. Living in Geneva – A City Home to Famous Educational Institutions. Living in Geneva Switzerland – A Guide to Geneva Transport. Guinea Pig and Budgie Owners under the Swiss Fed’s Thumb Can I Take Pets to Geneva? International Travel to Switzerland with Pets.
Simply Geneva
Skip to main content. Mind, Body, Soul. Theme images by Michael Elkan.
